vs
ACRES Commercial Realty Corp.（ACR）与Assertio Holdings, Inc.（ASRT）财务数据对比。点击上方公司名可切换其他公司
ACRES Commercial Realty Corp.的季度营收约是Assertio Holdings, Inc.的1.5倍（$20.0M vs $13.5M），ACRES Commercial Realty Corp.同比增速更快（-6.5% vs -57.9%），过去两年ACRES Commercial Realty Corp.的营收复合增速更高（3.3% vs -35.4%）
皮拉马尔地产是一家印度房地产企业，2012年成立，总部位于印度孟买，隶属于皮拉马尔集团。公司专注于住宅及商业地产开发，目前在手开发项目总规模约达1500万平方英尺，知名项目包括Piramal Aranya、Piramal Mahalaxmi等。
Assertio Therapeutics是一家美国专业制药企业，主要聚焦神经病学、疼痛以及中枢神经系统疾病领域的产品销售与推广。公司前身Depomed成立于1995年，总部位于加利福尼亚州纽瓦克，拥有多款获美国FDA批准的产品，目前在纳斯达克上市。
ACR vs ASRT — 直观对比
营收规模更大
ACR
是对方的1.5倍
$13.5M
营收增速更快
ACR
高出51.4%
-57.9%
两年增速更快
ACR
近两年复合增速
-35.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $20.0M | $13.5M |
| 净利润 | $6.3M | — |
| 毛利率 | — | — |
| 营业利润率 | 30.8% | -86.7% |
| 净利率 | 31.6% | — |
| 营收同比 | -6.5% | -57.9% |
| 净利润同比 | -32.0% | — |
| 每股收益（稀释后） | $-0.41 | $-4.54 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACRASRT
| Q4 25 | $20.0M | $13.5M | ||
| Q3 25 | $21.0M | $49.5M | ||
| Q2 25 | $21.9M | $29.2M | ||
| Q1 25 | $17.0M | $26.5M | ||
| Q4 24 | $21.4M | $32.2M | ||
| Q3 24 | $22.4M | $29.2M | ||
| Q2 24 | $20.9M | $31.1M | ||
| Q1 24 | $18.8M | $32.4M |
净利润ACRASRT
| Q4 25 | $6.3M | — | ||
| Q3 25 | $18.0M | $11.4M | ||
| Q2 25 | $4.3M | $-16.4M | ||
| Q1 25 | $-730.0K | $-13.5M | ||
| Q4 24 | $9.3M | — | ||
| Q3 24 | $8.1M | $-2.9M | ||
| Q2 24 | $6.4M | $-3.7M | ||
| Q1 24 | $4.9M | $-4.5M |
营业利润率ACRASRT
| Q4 25 | 30.8% | -86.7% | ||
| Q3 25 | 85.8% | 23.2% | ||
| Q2 25 | 19.8% | -27.5% | ||
| Q1 25 | -3.8% | -50.0% | ||
| Q4 24 | 43.4% | -41.9% | ||
| Q3 24 | 36.4% | -10.4% | ||
| Q2 24 | 30.8% | -11.6% | ||
| Q1 24 | 26.2% | -13.4% |
净利率ACRASRT
| Q4 25 | 31.6% | — | ||
| Q3 25 | 85.8% | 23.1% | ||
| Q2 25 | 19.8% | -56.0% | ||
| Q1 25 | -4.3% | -51.1% | ||
| Q4 24 | 43.5% | — | ||
| Q3 24 | 36.0% | -10.0% | ||
| Q2 24 | 30.6% | -11.8% | ||
| Q1 24 | 26.2% | -13.9% |
每股收益（稀释后）ACRASRT
| Q4 25 | $-0.41 | $-4.54 | ||
| Q3 25 | $1.34 | $0.11 | ||
| Q2 25 | $-0.10 | $-0.17 | ||
| Q1 25 | $-0.80 | $-0.14 | ||
| Q4 24 | $0.51 | $-3.28 | ||
| Q3 24 | $0.36 | $-0.03 | ||
| Q2 24 | $0.21 | $-0.04 | ||
| Q1 24 | $0.07 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $83.8M | $63.4M |
| 总债务越低越好 | $1.6B | — |
| 股东权益账面价值 | $420.8M | $94.0M |
| 总资产 | $2.2B | $267.0M |
| 负债/权益比越低杠杆越低 | 3.68× | — |
8季度趋势，按日历期对齐
现金及短期投资ACRASRT
| Q4 25 | $83.8M | $63.4M | ||
| Q3 25 | $40.9M | $93.4M | ||
| Q2 25 | $42.7M | $98.2M | ||
| Q1 25 | $66.0M | $87.3M | ||
| Q4 24 | $56.7M | $100.1M | ||
| Q3 24 | $70.1M | $88.6M | ||
| Q2 24 | $89.6M | $88.4M | ||
| Q1 24 | $84.6M | $80.7M |
总债务ACRASRT
| Q4 25 | $1.6B | — | ||
| Q3 25 | $1.2B | — | ||
| Q2 25 | $1.3B | — | ||
| Q1 25 | $1.3B | — | ||
| Q4 24 | $1.4B | — | ||
| Q3 24 | $1.5B | — | ||
| Q2 24 | $1.6B | — | ||
| Q1 24 | $1.6B | $38.6M |
股东权益ACRASRT
| Q4 25 | $420.8M | $94.0M | ||
| Q3 25 | $432.9M | $105.8M | ||
| Q2 25 | $425.3M | $93.3M | ||
| Q1 25 | $430.1M | $108.5M | ||
| Q4 24 | $439.1M | $121.1M | ||
| Q3 24 | $436.3M | $130.5M | ||
| Q2 24 | $434.0M | $132.2M | ||
| Q1 24 | $432.8M | $134.5M |
总资产ACRASRT
| Q4 25 | $2.2B | $267.0M | ||
| Q3 25 | $1.7B | $319.8M | ||
| Q2 25 | $1.8B | $273.8M | ||
| Q1 25 | $1.8B | $286.4M | ||
| Q4 24 | $1.9B | $284.7M | ||
| Q3 24 | $2.0B | $276.0M | ||
| Q2 24 | $2.1B | $279.4M | ||
| Q1 24 | $2.1B | $282.0M |
负债/权益比ACRASRT
| Q4 25 | 3.68× | — | ||
| Q3 25 | 2.76× | — | ||
| Q2 25 | 3.10× | — | ||
| Q1 25 | 2.97× | — | ||
| Q4 24 | 3.12× | — | ||
| Q3 24 | 3.43× | — | ||
| Q2 24 | 3.67× | — | ||
| Q1 24 | 3.79× | 0.29× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $4.1M | $-30.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 0.65× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ACRASRT
| Q4 25 | $4.1M | $-30.0M | ||
| Q3 25 | $-9.4M | $-4.8M | ||
| Q2 25 | $11.8M | $19.1M | ||
| Q1 25 | $-4.6M | $-12.5M | ||
| Q4 24 | $19.4M | $11.5M | ||
| Q3 24 | $8.4M | $-35.0K | ||
| Q2 24 | $6.9M | $7.4M | ||
| Q1 24 | $3.3M | $7.5M |
资本支出强度ACRASRT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率ACRASRT
| Q4 25 | 0.65× | — | ||
| Q3 25 | -0.52× | -0.42× | ||
| Q2 25 | 2.72× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 2.08× | — | ||
| Q3 24 | 1.05× | — | ||
| Q2 24 | 1.07× | — | ||
| Q1 24 | 0.68× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACR
| Other | $10.8M | 54% |
| Pacmulti JVLLC | $5.2M | 26% |
| Mccallum Jv Llc | $2.5M | 12% |
| Office Complex | $1.5M | 7% |
ASRT
| Products | $12.8M | 95% |
| Other | $719.0K | 5% |
